FDA說明Apple ECG.app的作用,實際以FDA/Apple的公開文件為主,請閱讀。

FDA給Apple Watch 是不是 De Novo classification ?
apple跟FDA的連結都在這裡,你們自己看。

吵FDA認證好無聊。
看英文就知道apple watch的ECG是什麼東西,不難懂啊。
他只是一個app。

apple文件下載點: https://www.apple.com/healthcare/site/docs/Apple_Watch_Arrhythmia_Detection.pdf

FDA文件下載點:FDA給予apple ECG App的文件說明

FDA:
The ECG app is a software-only mobile medical application intended for use with the Apple Watch to create, record, store, transfer, and display a single channel electrocardiogram (ECG) similar to a Lead I ECG. The ECG app determines the presence of atrial fibrillation (AFib) or sinus rhythm on a classifiable waveform. The ECG app is not recommended for users with other known arrhythmias.
The ECG app is intended for over-the-counter (OTC) use. The ECG data displayed by the ECG app is intended for informational use only. The user is not intended to interpret or take clinical action based on the device output without consultation of a qualified healthcare professional. The ECG waveform is meant to supplement rhythm classification for the purposes of discriminating AFib from normal sinus rhythm and not intended to replace traditional methods of diagnosis or treatment.



APPLE:

Overview
With the availability of watchOS 5.1.2 and Apple Watch Series 4, Apple Watch customers now have access to two features to detect heart arrhythmias such
as atrial fibrillation. Apple Watch Series 1 and later can look for arrhythmias using a photoplethysmograph-based algorithm, and the ECG app on Apple Watch Series 4 is capable of generating an ECG similar to a Lead I electrocardiogram. This app also classifies an ECG as sinus rhythm (SR), atrial fibrillation (AF), or inconclusive, and reports high or low heart rate. This paper is intended to provide a more detailed understanding of the capabilities of these features, including testing and validation.


FDA說明Apple ECG.app的作用,實際以FDA/Apple的公開文件為主,請閱讀。



FDA說明Apple ECG.app的作用,實際以FDA/Apple的公開文件為主,請閱讀。
FDA說明Apple ECG.app的作用,實際以FDA/Apple的公開文件為主,請閱讀。



Medical Device De Novo Classification Process的公開文件

The De Novo classification process is intended to provide an efficient pathway to ensure the most appropriate classification of a device consistent with the protection of the public health and the statutory scheme for device regulation.

財團法人醫藥品查驗中心:
http://www.cde.org.tw/Content/Files/Knowledge/e5a179f4-2ba6-415b-ae2e-05bf0e162b5f.pdf

FDA給Apple的文件,以及De Novo classification的中文說明.zip

個人解讀:
ECG.app是De Novo classification,不具有實質等同性(substantial equivalent)。 所以,他們文件都宣稱ECG.app是一種創新的單通道(single channel detector)搭配AI演算法應用。所以預設搭配ECG.app的apple watch,得到一個具有ECG.app的硬體裝置。實質看文件內容可以發現,這個ECG.app軟體是FDA給予的標示,而非手錶本體。

分開看,
假設ECG.app是販售的app軟體,在apple store裡面做app上架,請問政府會管嗎?
或是發文限制apple不准給使用者下載這個app,以及不准app具有健康功能嗎?
心律app可以,但是ECG app卻不可?兩套標準。

講穿了就因為watch內建app,所以搭配組合,政府就是要管device裝置。
但,他管不了app,只要ECG.app是 apple store販售或是下載,由使用者決定就好,這就可以迴避ECG.app的審查。
Selma wrote:
FDA給Apple Watch...(恕刪)

專業,but.........政府看不到,當官的能少一事就少一事
透過AI去做醫學應用,也沒看到哪個AI應用可以宣稱取代醫療實質的判定。

早期用手指按著手電筒,然後出現心跳次數。這是一種創新研究,我會當作參考,而非判定,因為真的不準啊。
app本身準確率不高,大家都知道要找專業的機器去確認。
因為那個app,害我就因此買了兩台歐姆龍血壓機。

創新,毀在死板板的公務系統裡面。
如果這樣害怕創新的研究,不如科技部現在限制全台灣禁止做生技檢測的AI演算法開發。

科技部希望開發AI,我們卻用法規把門關起來。
滿妙的,到底開放研究還是限制研究?

Watch 一開始就不要說ECG,就沒事。可惜了~
文章分享
評分
評分
複製連結

今日熱門文章 網友點擊推薦!